Gene · 442915
MIR370: microRNA 370
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR370: microRNA 370. Genes, record 442915. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/442915
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants423
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR370 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P20GM103408 | Idaho INBRE Program | 1 | 2025 |
| P20GM103424 | Louisiana Biomedical Research Network | 1 | 2025 |
| P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 1 | 2025 |
| P20GM103466 | HAWAII INBRE V PROGRAM | 1 | 2025 |
| P20GM113123 | Center for Excellence in Host Pathogen Interactions | 1 | 2025 |
| P20GM121334 | Mississippi Center of Excellence in Perinatal Research, Phase 2 | 1 | 2025 |
| P30AG015272 | Center for Aging in Diverse Communities: Ending Health Inequities in Older Adults | 1 | 2025 |
| P30AI045008 | Penn Center for AIDS Research | 1 | 2025 |
1 to 10 of 423Source NIH's project files
See all 423 nih grantsPapers1,407
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-Transcriptome Profiling of Ovarian Tissues in Gilts with Normal Estrus and Follicular Cyst-Associated Anestrus. | Int J Mol Sci | 2026 | 42589503 | PubTator, text mining | PubMed |
| circLDHC controls sertoli cell maturation and metabolic remodeling through the miR-370-AR axis. | Mol Cell Endocrinol | 2026 | 42492653 | PubTator, text mining | PubMed |
| Protective effect of ischemic preconditioning against hepatic ischemia-reperfusion injury and associated remote organ damage. | World J Gastrointest Surg | 2026 | 41809327 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers. | Front Cell Dev Biol | 2025 | 41378310 | PubTator, text mining | PubMed |
Significant Association Between Abundance of Gut Microbiota and Plasma Levels of microRNAs in Individuals with Metabolic Syndrome and Their Potential as Biomarkers for Metabolic Syndrome: A Pilot Study. | Genes (Basel) | 2025 | 41153378 | PubTator, text mining | PubMed |
| Refining Flow Cytometry-based Sorting of Plasma-derived Extracellular Vesicles. | Biol Proced Online | 2025 | 40836218 | PubTator, text mining | PubMed |
| Progress of targeted FOX family therapy in ovarian cancer. | Front Pharmacol | 2025 | 40746724 | PubTator, text mining | PubMed |
| Retraction Notice to: hsa_circ_0061140 Knockdown Reverses FOXM1- Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity. | Mol Ther Nucleic Acids | 2025 | 40606643 | PubTator, text mining | PubMed |
| [Omics Study of Ovarian Malignancies: From Urine Metabolomic Profile to Minimally Invasive MicroRNA Markers]. | Mol Biol (Mosk) | 2025 | 40542633 | PubTator, text mining | PubMed |
1 to 10 of 1,407
See all 1,407 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/442915
GET https://conductscience.org/api/genes/v1/442915/grants?page=2